Clinical Trial Update: Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial sponsored by NINDS is evaluating blood-brain barrier breakdown using manganese-enhanced MRI in people with drug-resistant epilepsy; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Epilepsy | Phase 1 | Status: RECRUITING